Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/25/22 → 01/23/25 |
Funding
- Lilly USA LLC: $71,037.00
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide versus Placebo in Patients with Heart Failure with Preserved Ejection Fraction and Obesity (SUMMIT)
- Skopicki, Hal (PI)
- Tam, Edlira (CoPI)
- Pilato, Lauren (CoPI)
Project: Research